SCHEMBL7347264

SCHEMBL7347264

Nc1cc2c(ccc3cnccc32)[nH]c1=O

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 1/20 0.47
CCND1 P24385 1/20 0.47
PARP1 P09874 5/20 0.45
DAO P14920 2/20 0.45
IMPDH2 P12268 3/20 0.45
LMNA P02545 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
BRAF P15056 1/20 0.43
PDE3B Q13370 2/20 0.42
PDE3A Q14432 2/20 0.42
CHUK O15111 3/20 0.42
FGFR1 P11362 1/20 0.40
FLT1 P17948 1/20 0.40
AURKB Q96GD4 1/20 0.40
INCENP Q9NQS7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7348155 0.80 DAO (0.44) CDK4CCND1PARP1DAOBRAF
SCHEMBL7340847 0.78 DYRK1A (0.49) CDK4CCND1PARP1DAOLMNA
SCHEMBL7339379 0.78 PARP1 (0.57) PARP1LMNACYP1A2
SCHEMBL7346243 0.74 TYMS (0.50) PARP1DAOLMNACYP1A2
SCHEMBL10812608 0.70 PDE3B (0.60) PARP1CYP1A2CYP3A4CYP2D6PDE3B
SCHEMBL7346958 0.70 PARP1 (0.41) PARP1DAOLMNACYP1A2CYP2C19
SCHEMBL445595 0.70 IMPDH2 (0.58) CDK4CCND1IMPDH2LMNACYP1A2
SCHEMBL30963037 0.69 CHUK (0.65) CDK4CCND1BRAFCHUK
SCHEMBL10642567 0.69 CHUK (0.65) CDK4CCND1BRAFCHUK
SCHEMBL13687857 0.68 PARP1 (0.63) PARP1IMPDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4511569-A Tricyclic lactams and derivatives useful in increasing cardiac contractility SCHERING CORPORATION (US) 1985-04-16 US disclosed
EP-0102046-A1 Tricyclic lactams, method for making them, pharmaceutical compositions containing them SCHERING CORPORATION (US) 1984-03-07 EP disclosed